Véronique Rabenda

Summary

Country: Belgium

Publications

  1. doi request reprint Relationship between use of antidepressants and risk of fractures: a meta-analysis
    V Rabenda
    Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Bât B23, 4000, Liege, Belgium
    Osteoporos Int 24:121-37. 2013
  2. ncbi request reprint Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants
    Véronique Rabenda
    Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
    Bone 51:674-9. 2012
  3. ncbi request reprint [Numerus clausus at the end of the third year of medical school]
    V Rabenda
    Service de Sante Publique, épidémiologie et économie de la santé, Universite de Liege, Liege
    Rev Med Liege 58:508-14. 2003
  4. doi request reprint Low incidence of anti-osteoporosis treatment after hip fracture
    Véronique Rabenda
    Department of Public Health, Epidemiology and Health Economics, 3, Avenue de l Hôpital Bat B23, Liege, Belgium
    J Bone Joint Surg Am 90:2142-8. 2008
  5. doi request reprint Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence
    Véronique Rabenda
    University of Liege, Department of Public Health, Epidemiology and Health Economics, Liege, Belgium
    Expert Opin Pharmacother 10:2303-15. 2009
  6. doi request reprint Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures
    V Rabenda
    Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Bât B23, 4000, Liege, Belgium
    Osteoporos Int 21:1993-2002. 2010
  7. ncbi request reprint [Prevention and treatment of osteoporosis: avoiding clinical inertia and promoting therapeutic adherence]
    V Rabenda
    Departement de sante publique, épidémiologie et économie de la santé, Universite de Liege, CHU de Liege, Belgique
    Rev Med Liege 65:358-65. 2010
  8. doi request reprint Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression
    V Rabenda
    Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Bât B23, 4000 Liege, Belgium
    Osteoporos Int 22:893-901. 2011
  9. doi request reprint Overcoming problems with adherence to osteoporosis medication
    Véronique Rabenda
    Department of Public Health, Epidemiology and Health Economics, CHU Bât B23, 4000 Liege, Belgium
    Expert Rev Pharmacoecon Outcomes Res 10:677-89. 2010
  10. ncbi request reprint Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
    V Rabenda
    WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, University of Liege, Liege, Belgium
    Osteoporos Int 19:811-8. 2008

Detail Information

Publications25

  1. doi request reprint Relationship between use of antidepressants and risk of fractures: a meta-analysis
    V Rabenda
    Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Bât B23, 4000, Liege, Belgium
    Osteoporos Int 24:121-37. 2013
    ..Results from this large meta-analysis show that both SSRIs and TCAs are associated with a moderate and clinically significant increase in the risk of fractures of all types...
  2. ncbi request reprint Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants
    Véronique Rabenda
    Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
    Bone 51:674-9. 2012
    ..To examine the association between antidepressants, including TCAs, SSRIs, and miscellaneous antidepressants and the risk of nonvertebral fractures among women with osteoporosis...
  3. ncbi request reprint [Numerus clausus at the end of the third year of medical school]
    V Rabenda
    Service de Sante Publique, épidémiologie et économie de la santé, Universite de Liege, Liege
    Rev Med Liege 58:508-14. 2003
    ....
  4. doi request reprint Low incidence of anti-osteoporosis treatment after hip fracture
    Véronique Rabenda
    Department of Public Health, Epidemiology and Health Economics, 3, Avenue de l Hôpital Bat B23, Liege, Belgium
    J Bone Joint Surg Am 90:2142-8. 2008
    ....
  5. doi request reprint Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence
    Véronique Rabenda
    University of Liege, Department of Public Health, Epidemiology and Health Economics, Liege, Belgium
    Expert Opin Pharmacother 10:2303-15. 2009
    ..There is an urgent need to implement strategies and to encourage physicians to take measures that increase patients' awareness of the need to use osteoporosis medications as directed in order to benefit from them fully...
  6. doi request reprint Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures
    V Rabenda
    Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Bât B23, 4000, Liege, Belgium
    Osteoporos Int 21:1993-2002. 2010
    ..This paper relates the relationship existing between adherence to strontium ranelate and the risk of subsequent nonvertebral fracture among postmenopausal women with osteoporosis...
  7. ncbi request reprint [Prevention and treatment of osteoporosis: avoiding clinical inertia and promoting therapeutic adherence]
    V Rabenda
    Departement de sante publique, épidémiologie et économie de la santé, Universite de Liege, CHU de Liege, Belgique
    Rev Med Liege 65:358-65. 2010
    ..The once monthly oral, quaterly or annual intravenous (bisphosphonates), or else subcutaneous, every 6 months (denosumab) formulations may potentially improve adherence...
  8. doi request reprint Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression
    V Rabenda
    Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Bât B23, 4000 Liege, Belgium
    Osteoporos Int 22:893-901. 2011
    ..Our results suggest that bone mineral density (BMD)changes cannot be used as a surrogate of anti-fracture efficacy, among patients receiving calcium, with or without vitamin D...
  9. doi request reprint Overcoming problems with adherence to osteoporosis medication
    Véronique Rabenda
    Department of Public Health, Epidemiology and Health Economics, CHU Bât B23, 4000 Liege, Belgium
    Expert Rev Pharmacoecon Outcomes Res 10:677-89. 2010
    ..Improved patient education, enhancing healthcare provider-patients interaction, taking into account patient's preferences and involving them in treatment decisions may improve adherence...
  10. ncbi request reprint Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
    V Rabenda
    WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, University of Liege, Liege, Belgium
    Osteoporos Int 19:811-8. 2008
    ..This paper relates the strong relationship existing between adherence to anti-osteoporosis treatment and the risk of subsequent hip fracture...
  11. pmc A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs
    V Rabenda
    Department of Epidemiology, Public Health and Health Economics, University of Liege, Belgium
    Ann Rheum Dis 64:688-93. 2005
    ..To capture changes in the quality of life (QoL) occurring in patients with osteoarthritis (OA) during treatment with non-specific non-steroidal anti-inflammatory drugs (NSAIDs) and to identify factors that predict such changes...
  12. ncbi request reprint Prevalence and impact of osteoarthritis and osteoporosis on health-related quality of life among active subjects
    Véronique Rabenda
    WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Department of Public Health, Epidemiology and Health Economics, University of Liege, 4000 Liege, Belgium
    Aging Clin Exp Res 19:55-60. 2007
    ..To assess the prevalence and impact of osteoarthritis (OA) and osteoporosis (OP) on health-related quality of life (HRQOL) among active subjects employed in the public workforce in Belgium...
  13. ncbi request reprint The direct and indirect costs of the chronic management of osteoporosis: a prospective follow-up of 3440 active subjects
    V Rabenda
    Department of Public Health, Epidemiology and Health Economics, CHU, Bat B23, 4000 Liege, Belgium
    Osteoporos Int 17:1346-52. 2006
    ..The objective of this study was to estimate the direct and indirect costs attributable to osteoporosis (OP) from a societal and a payer's perspective among active subjects living in Belgium and employed in the public workforce...
  14. ncbi request reprint Direct and indirect costs attributable to osteoarthritis in active subjects
    Véronique Rabenda
    Deaprtment of Public Health, Epidemiology and Health Economics, Unviersity of Liège, 4000 Liege, Belgium
    J Rheumatol 33:1152-8. 2006
    ..To estimate the direct and indirect costs of osteoarthritis (OA) in an active population, and to identify factors significantly influencing these expenditures...
  15. ncbi request reprint Determinants of gastro-protective drugs co-prescription during treatment with nonselective NSAIDs: a prospective survey of 2197 patients recruited in primary care
    V Rabenda
    Department of Epidemiology, Public Health and Health Economics, University of Liege, Liege, Belgium
    Osteoarthritis Cartilage 14:625-30. 2006
    ....
  16. ncbi request reprint Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence
    Mickael Hiligsmann
    HEC ULg Management School, University of Liege, Liege, Belgium
    Value Health 13:394-401. 2010
    ..To estimate the impact of medication adherence on the cost-effectiveness of mass-screening by bone densitometry followed by alendronate therapy for women diagnosed with osteoporosis...
  17. doi request reprint The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients
    Mickael Hiligsmann
    HEC School of Management, Department of Economics, University of Liege, Boulevard du Rectorat 7, Liege 1, Belgium
    Health Policy 96:170-7. 2010
    ..This study aims to estimate the clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients and the potential cost-effectiveness of adherence-enhancing interventions...
  18. doi request reprint Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women
    Olivier Bruyere
    Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Sart Tilman, Bat B23, 4000, Liege, Belgium
    Eur J Epidemiol 24:707-12. 2009
    ..However, spine BMD changes do not influence vertebral fracture incidence...
  19. ncbi request reprint Potential clinical and economic impact of nonadherence with osteoporosis medications
    Mickael Hiligsmann
    HEC ULg Management School, University of Liege, Boulevard du Rectorat 7, Bât B31, 4000 Liege, Belgium
    Calcif Tissue Int 86:202-10. 2010
    ..Adherence therefore remains an important challenge for health-care professionals treating osteoporosis...
  20. ncbi request reprint Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years
    Olivier Bruyere
    Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU Sart Tilman, Bat B23, 4000, Liege, Belgium
    Calcif Tissue Int 93:502-7. 2013
    ..Our results suggest that changes in symptoms and, more particularly, in structure over 3 years in patients with osteoarthritis reflect a clinically relevant progression of the disease...
  21. ncbi request reprint Adherence, patient preference and dosing frequency: understanding the relationship
    J Y Reginster
    WHO Collaborating Center for Public Health Aspects of Rheumatic Diseases, University of Liege, Liege, Belgium
    Bone 38:S2-6. 2006
    ..A novel once-monthly bisphosphonate regimen, such as the ibandronate regimen, may therefore help patients to follow dosing guidelines and encourage them to stay on therapy longer, thereby improving overall therapy effectiveness...
  22. ncbi request reprint [Adherence to treatment in osteoporosis influence on efficiency]
    J Y Reginster
    Unité d exploration du métabolisme de l os et du cartilage CHU Centre Ville 45, Quai Godefroid Kurth 4020 Liège, Belgique
    Rev Med Suisse 1:2278-81. 2005
    ..New medications, currently developed for the management of osteoporosis, will be user-friendly, allowing to an improvement of compliance and persistence...
  23. pmc Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach
    F Richy
    Santé Publique, épidémiologie et économie de la santé, CHU, Bat B23, B 4000 Sart Tilman, Belgium, Europe
    Ann Rheum Dis 63:759-66. 2004
    ..To provide an updated document assessing the global, NSAID-specific, and time dependent risk of gastrointestinal (GI) complications through meta-analyses of high quality studies...
  24. ncbi request reprint Flurbiprofen in the symptomatic management of rheumatoid arthritis: a valuable alternative
    F Richy
    Department of Public Health, Epidemiology and Health Economics, University of Liege, and WHO Collaborating Center on Public Health Aspects of Osteoarticular Disorders, Liege, Belgium
    Int J Clin Pract 61:1396-406. 2007
    ..The aim of this comprehensive meta-analysis was to evaluate the absolute and relative efficacy and safety of flurbiprofen in the management of rheumatoid arthritis...
  25. pmc Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
    Jean Yves Reginster
    WHO Collaborating Center for Public Health Aspects of Rheumatic Diseases, University of Liege, Liege, Belgium
    Clin Interv Aging 1:415-23. 2006
    ..It is important that physicians consider patient preference when prescribing treatment for osteoporosis to ensure that the disease is effectively managed for the long-term benefit of the patient...